- NBSE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
NeuBase Therapeutics (NBSE) S-3Shelf registration
Filed: 15 Sep 17, 12:00am
Exhibit 12.1
STATEMENT REGARDING COMPUTATION OF RATIOS
Year Ended September 30, | Nine Months Ended June 30, | |||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | |||||||||||||||||||
(in thousands) | ||||||||||||||||||||||||
Computation of Earnings: | ||||||||||||||||||||||||
Pretax loss | $ | (1,454,884.00 | ) | $ | (5,652,488.00 | ) | $ | (9,130,664.00 | ) | $ | (15,197,865.00 | ) | $ | (25,766,198.00 | ) | $ | (18,566,555.00 | ) | ||||||
Adjustments to earnings: | ||||||||||||||||||||||||
Fixed charges (as computed below) | $ | 1,817.02 | $ | 4,689.38 | $ | 33,149.92 | $ | 113,101.18 | $ | 118,813.61 | $ | 85,447.19 | ||||||||||||
Earnings as adjusted | $ | (1,453,066.98 | ) | $ | (5,647,798.62 | ) | $ | (9,097,514.08 | ) | $ | (15,084,763.82 | ) | $ | (25,647,384.39 | ) | $ | (18,481,107.82 | ) | ||||||
Computation of Fixed Charges: | ||||||||||||||||||||||||
Capitalized interest | $ | 1,817.02 | $ | 4,689.38 | $ | 5,576.32 | $ | 5,977.52 | $ | 6,592.58 | $ | 6,274.74 | ||||||||||||
Estimated interest component of rent expense | $ | 27,573.60 | $ | 107,123.66 | $ | 112,221.03 | $ | 79,172.45 | ||||||||||||||||
Total fixed charges | $ | 1,817.02 | $ | 4,689.38 | $ | 33,149.92 | $ | 113,101.18 | $ | 118,813.61 | $ | 85,447.19 | ||||||||||||
Deficiency of earnings available to cover | 1,454,884.00 | (a) | 5,652,488.00 | (a) | 9,130,664.00 | (a) | 15,197,865.00 | (a) | 25,766,198.00 | (a) | 18,566,550.01 | (a) |
(a) Earnings were inadequate to cover combined fixed charges for the periods presented.